Teva Pharmaceutical Industries | TEVA - Operating Profit

Stock Price
9,270.00
Daily Change
71.00 0.77%
Monthly
-0.18%
Yearly
71.70%
Q2 Forecast
8,997.46

Teva Pharmaceutical Industries reported $487M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Aspen Pharmacare ZAR 3.76B 1.04B Dec/2025
Cipla INR 9.77B 6.21B Dec/2025
Dr.Reddys Laboratories INR 13.94B 2.31B Dec/2025
Guangzhou Baiy CNY -661.07M 2B Dec/2025
Jiangsu Hengrui CNY 2.56B 302M Mar/2026
Kalbe Farma IDR 851.77B 208.4B Sep/2025
Richter Gedeon HUF 63.58B 6.08B Sep/2025
Sh Fosun Pharma CNY 864.14M 105.76M Dec/2025
Sun Pharmaceuticals INR 33.67B 49.9M Sep/2025
Teva Pharmaceutical Industries USD 487M 581M Dec/2025